ACTIVATION OF THE AhR/ARNT PATHWAY IS ASSOCIATED WITH OUTCOME OF DLBCL PATIENTS AFTER TREATED WITH RITUXIMAB

Hematological Oncology - United Kingdom
doi 10.1002/hon.27_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search